Fabio Arias
Granada, AN, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Targeting Oxalate Production by Combining Enzyme Inhibition and Proteolysis Activation: A Novel Therapeutic Approach for Primary Hyperoxaluria Type 1.
Journal: Journal of medicinal chemistry
Published: January 02, 2026
Metabolic Pathways Linking Atherosclerotic Cardiovascular Disease With Metabolic Dysfunction-Associated Steatotic Liver Disease.
Journal: Current atherosclerosis reports
Published: December 13, 2025
Neutrophil Integrin α9 Impairs Efferocytosis and Worsens Long-Term Recovery After Subarachnoid Hemorrhage.
Journal: Arteriosclerosis, thrombosis, and vascular biology
Published: July 31, 2025
Sex-based multiomics analysis uncovers metabolic and molecular mediators linking MASH and atherosclerosis.
Journal: JHEP reports : innovation in hepatology
Published: March 10, 2025
NMR spectroscopy study of new imidamide derivatives as nitric oxide synthase inhibitors.
Journal: Magnetic resonance in chemistry : MRC
Published: March 03, 2022
Bioactive imidamide-based compounds targeted against nitric oxide synthase.
Journal: Bioorganic chemistry
Published: September 15, 2021
Synthesis, bioevaluation and docking studies of new imidamide derivatives as nitric oxide synthase inhibitors.
Journal: Bioorganic & medicinal chemistry
Published: May 11, 2021
Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation.
Journal: ACS medicinal chemistry letters
Published: May 27, 2020
Quinazolinones, Quinazolinthiones, and Quinazolinimines as Nitric Oxide Synthase Inhibitors: Synthetic Study and Biological Evaluation.
Journal: Archiv der Pharmazie
Published: January 22, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026